A 434 New Jersey General Assembly · 2026-2027 Regular Session

Prohibits SHBP, SEHBP, and Medicaid from denying coverage for maintenance medications for chronic conditions for covered persons solely because of change in health benefits plan or pharmacy benefits manager.

This bill prevents New Jersey's State Health Benefits Program (SHBP), School Employees' Health Benefits Program (SEHBP), and Medicaid from denying coverage for maintenance medications treating chronic conditions when a person's health plan or pharmacy provider changes. It requires coverage continuity if a patient was taking the medication before the plan change and the new plan covers that specific drug class. The law applies to state employees, school staff, and Medicaid recipients who rely on ongoing medication for conditions like diabetes or hypertension. It ensures these individuals won't lose access to essential medications due solely to administrative shifts in their health coverage plans.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 13, 2026 Last action Feb 12, 2026
Maddy AI version diff · 1 comparison

What changed between versions

Technical Review Of Prefiled Bill Introduced · 3 edits · Jan 13, 2026
MINOR
The bill transitioned from a technical review stage to its introduced version. The primary substantive addition is a new STATEMENT section that summarizes the bill's purpose: prohibiting SHBP, SEHBP, and Medicaid plans from denying coverage for maintenance medications prescribed for chronic conditions when the denial results solely from a change in the health benefits plan or pharmacy benefits manager. Administrative changes include removal of the 'TR' designation and a co-sponsor listing.
SCOPE

A new STATEMENT section was added summarizing that the bill prohibits SHBP, SEHBP, and Medicaid from denying coverage for maintenance medications for chronic conditions when the denial is caused solely by a change in the health benefits plan or pharmacy benefits manager. The statement clarifies the prohibition applies only if the person was already taking the medication before the change and the new plan covers that drug class.

TECHNICAL

The bill status changed from 'As reported by the Assembly Financial Institutions and Insurance Committee with technical review' to 'Introduced Pending Technical Review by Legislative Counsel,' reflecting its progression through the legislative process.

Co-sponsor information (Assemblyman Kearney) was removed, along with the 'TR' suffix from the bill number, consistent with the transition to the introduced version.

Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Feb 12, 2026
Committee
Reported and Referred to Assembly Health Committee
lower
Jan 13, 2026
Introduced
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
lower
3 primary · 0 co-sponsors

Sponsors